In addition, a previous work found that different AD genetic variants (APP/presenilin 1 (PSEN1)/PSEN2 and triggering receptor expressed on myeloid cells 2 (TREM2)) showed differential metabolomic and lipidomic profiles [42]. This evidence concerns the gene APP and Alzheimer disease.